Clinical characteristics and outcomes in patients with COVID-19 and cancer: a systematic review and meta-analysis

P Zarifkar, A Kamath, C Robinson, N Morgulchik… - Clinical Oncology, 2021 - Elsevier
Much of routine cancer care has been disrupted due to the perceived susceptibility to SARS-
CoV-2 infection in cancer patients. Here, we systematically review the current evidence base …

Global Prevalence of Nosocomial Multidrug-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis

NA Mohd Asri, S Ahmad, R Mohamud, N Mohd Hanafi… - Antibiotics, 2021 - mdpi.com
The emergence of nosocomial multidrug-resistant Klebsiella pneumoniae is an escalating
public health threat worldwide. The prevalence of nosocomial infections due to K …

Old and new beta-lactamase inhibitors: Molecular structure, mechanism of action, and clinical Use

D Carcione, C Siracusa, A Sulejmani, V Leoni, J Intra - Antibiotics, 2021 - mdpi.com
The β-lactams have a central place in the antibacterial armamentarium, but the increasing
resistance to these drugs, especially among Gram-negative bacteria, is becoming one of the …

Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index

EY Klein, KK Tseng, S Pant, R Laxminarayan - BMJ global health, 2019 - gh.bmj.com
Background Evaluating trends in antibiotic resistance and communicating the results to a
broad audience are important for dealing with this global threat. The Drug Resistance Index …

β-lactam antibiotics and β-lactamase enzymes inhibitors, part 2: our limited resources

S Alfei, AM Schito - Pharmaceuticals, 2022 - mdpi.com
β-lactam antibiotics (BLAs) are crucial molecules among antibacterial drugs, but the
increasing emergence of resistance to them, developed by bacteria producing β-lactamase …

Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey

J Seni, SG Mapunjo, R Wittenauer, R Valimba… - BMJ open, 2020 - bmjopen.bmj.com
Objective To delineate the prevalence and factors associated with antimicrobial use across
six referral hospitals in Tanzania using WHO point prevalence survey (PPS) methodology to …

[HTML][HTML] Genetic determinants of resistance among ESBL-producing enterobacteriaceae in community and hospital settings in east, central, and Southern Africa: A …

OG Onduru, RS Mkakosya, S Aboud… - Canadian Journal of …, 2021 - hindawi.com
Background. The world prevalence of community and hospital-acquired extended-spectrum
β-lactamase (ESBL)-producing Enterobacteriaceae is increasing tremendously. Bacteria …

Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan

S Abrar, S Hussain, RA Khan, N Ul Ain… - … Resistance & Infection …, 2018 - Springer
Abstract Background South-Asia is known as a hub for multidrug-resistant (MDR) bacteria.
Unfortunately, proper surveillance and documentation of MDR pathogens is lacking in …

High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

F Moges, S Eshetie, W Abebe, F Mekonnen… - PloS one, 2019 - journals.plos.org
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

TEM,CTX-M,SHV Genes in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Isolated from Clinical Samples in a County Clinical Emergency Hospital …

AE Ghenea, OM Zlatian, OM Cristea, A Ungureanu… - Antibiotics, 2022 - mdpi.com
Background: CTX-M betalactamases have shown a rapid spread in the recent years among
Enterobacteriaceae and have become the most prevalent Extended Spectrum Beta …